ADIAL PHARMACEUTICALS, INC.
Recent Filings
All 522 filings →| Form | Description | Date |
|---|---|---|
| 8-K | CURRENT REPORT | Mar 6, 2026 |
| 10-K | ANNUAL REPORT | Mar 5, 2026 |
| 8-K | CURRENT REPORT | Mar 3, 2026 |
| 8-K | CURRENT REPORT | Feb 24, 2026 |
| SCHEDULE 13G | — | Feb 18, 2026 |
| 8-K | CURRENT REPORT | Feb 4, 2026 |
| 8-K | CURRENT REPORT | Jan 6, 2026 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | Jan 6, 2026 |
| PRE 14A | PRELIMINARY PROXY STATEMENT | Dec 23, 2025 |
| 424B5 | PROSPECTUS SUPPLEMENT | Dec 19, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Schuyler Kevin | — | Purchase | 700 @ $2.74 | 700 | Sep 29, 2023 |
| Truluck Joseph | Chief Financial Officer | Award / Grant | 157,500 | 265,139 | May 23, 2023 |
| Stilley William B. III | — | Award / Grant | 240,800 | 1,261,779 | May 23, 2023 |
| Claiborne Cary J | Chief Executive Officer | Award / Grant | 420,000 | 1,520,000 | May 23, 2023 |
| Claiborne Cary J | Chief Executive Officer | Award / Grant | 25,000 @ $0.43 | 1,025,000 | Sep 20, 2022 |
| Claiborne Cary J | Chief Executive Officer | Award / Grant | 1,000,000 | 1,000,000 | Aug 18, 2022 |
| Stilley William B. III | Chief Executive Officer | Award / Grant | 250,000 | 1,187,646 | Feb 23, 2022 |
| Newman James W. Jr. | — | Purchase | 10,000 @ $2.71 | 34,644 | Dec 30, 2021 |
| Stilley William B. III | Chief Executive Officer | Purchase | 10,000 @ $2.59 | 927,046 | Nov 30, 2021 |
| Newman James W. Jr. | — | Purchase | 10,000 @ $2.85 | 34,475 | Nov 26, 2021 |